Yale Faculty Release Statement on Hydroxychloroquine and Covid-19

Several health experts at Yale have published a signed letter expressing their concern about the advocacy of their colleague, Dr. Harvey Risch, who is promoting hydroxychloroquine as a Covid-19 treatment. They write:

“As his colleagues, we defend the right of Dr. Risch, a respected cancer epidemiologist, to voice his opinions. But he is not an expert in infectious disease epidemiology and he has not been swayed by the body of scientific evidence from rigorously conducted clinical trials, which refute the plausibility of…